No. 25A901

Eli Lilly and Company v. United States, et al., ex. rel., Ronald J. Streck

Lower Court: Seventh Circuit
Docketed: 2026-02-09
Status: Application
Type: A
Experienced Counsel
Tags: average-manufacturer-price false-claims-act medicaid-rebate pharmaceutical-regulation qui-tam statutory-interpretation
Latest Conference: N/A
Question Presented (from Petition)

Question not identified.

The petition text provided is an "Application for an Extension of Time" to file a petition for certiorari, not a petition for certiorari itself. It does not contain a "Question(s) Presented" section. The document presents background facts and context about the case, but does not include the formal "Question Presented" section that would appear in an actual petition for a writ of certiorari.

Question Presented (AI Summary)

Whether a pharmaceutical manufacturer's objectively reasonable interpretation of an ambiguous Medicaid rebate statute can constitute a false claim under the False Claims Act when the government did not provide clear guidance

Docket Entries

2026-02-09
Application (25A901) granted by Justice Barrett extending the time to file until March 21, 2026.
2026-02-04
Application (25A901) to extend the time to file a petition for a writ of certiorari from February 19, 2026 to March 21, 2026, submitted to Justice Barrett.

Attorneys

Eli Lilly and Company
Erin E. MurphyClement & Murphy, PLLC, Petitioner
Erin E. MurphyClement & Murphy, PLLC, Petitioner
Ronald J. Streck
D. John SauerSolicitor General, Respondent
D. John SauerSolicitor General, Respondent